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AA epoxygenase activity (37-39). Similarly, in human and rat kidney, CYP2C isoforms are responsible for the majority of EET biosynthesis (30, 40) . In contrast, in human and rat heart, CYP2J isoforms are particularly abundant and have been proposed to be the predominant enzymes responsible for epoxidation of endogenous AA pools (34, 41) .
Both CYP2J and CYP2C isoforms appear to contribute to EET biosynthesis in vascular endothelial cells, although their relative contribution remains unknown (21, (42) (43) (44) . In most tissues, however, the relative contribution of different P450s to EET biosynthesis remains unknown due to the absence of P450 isoform specific chemical inhibitors and inhibitory antibodies.
EET biosynthesis can be altered by factors that affect P450 expression and/or activity. Treatment of rats with phenobarbital induces CYP2B subfamily P450s leading to increased hepatic AA epoxygenase activity and altered regio-and stereochemical selectivity of rat liver EETs (35, 45) . In contrast, treatment of rats with the aromatic hydrocarbon β-naphthoflavone results in reduced hepatic AA epoxygenase activity and a concomitant increase in the formation of ω-terminal HETEs (35) . The effects of aromatic hydrocarbons on P450 epoxygenase activity are species-dependent.
Treatment of fish and avian species with benzo(a)pyrene or 2,3,7,8-tetrachlorodibenzop-dioxin increases hepatic EET biosynthesis, likely by inducing CYP1A subfamily P450s (46,47).
Nutritional factors can modulate P450-dependent AA metabolism. Fasting leads to reduced hepatic CYP2C11 expression and decreased epoxygenase activity in rats (48). EET biosynthesis is increased in vascular tissue isolated from rabbits fed a cholesterol-rich diet compared to control rabbits suggesting that dietary cholesterol by guest on http://www.jbc.org/ Downloaded from alters P450 AA metabolism (49) . Dietary salt has been shown to induce rat kidney CYP2C23 resulting in increased renal EET biosynthesis and enhanced urinary secretion of epoxygenase metabolites (40,50,51).
Genetic variation in human P450 genes is well described; however, little is known about the effect of P450 genetic polymorphism on AA metabolic pathways. A coding polymorphism in the human CYP2C8 gene (CYP2C8*3), which includes both Arg139Lys and Lys399Arg amino acid substitutions, has been shown to result in significantly reduced AA epoxygenase activity (52) . We have recently identified several polymorphisms within the CYP2J2 gene which result in non-conservative amino acid substitutions that affect P450 enzyme function (L. King and D.C. Zeldin, unpublished data). It is not yet known whether the frequency of these polymorphisms is altered in diseased patients.
Metabolic Fate of the EETs
Once formed, the EETs can be further metabolized along a number of pathways as illustrated in Figure 3 . Capdevila and co-workers have documented the presence of glycerophospholipids which contain an epoxyeicosatrienoate moiety esterified to the glycerol-sn-2 position (53,54). These novel EET-PLs are formed in vivo by a multienzyme process initiated by P450 epoxidation of AA followed by ATP-dependent activation to epoxyeicosatrienoyl-CoA derivatives, and finally regio-and stereoselective lysolipid acylation (54) . In fact, the majority (>85%) of endogenous EETs present in mammalian tissues are esterified to cellular glycerophospholipids. Importantly, it has recently been shown that 1-palmitoyl-2-epoxyeicosatrienoyl phosphatidylcholine significantly inhibits the activity of porcine L-type Ca ++ channels reconstituted into planar lipid bilayers, suggesting that these EET-PLs may be involved in the regulation of membrane ion permeabilities (55 Incubations of EETs with rat or mouse liver microsomal P450 results in the production of a series of diepoxyeicosadienoic acids (diepoxides) and monohydroxyepoxyeicosatrienoic acids (epoxyalcohols) (59, 65) . The diepoxides can be further metabolized by sEH to diol epoxides which cyclize to the corresponding tetrahydrofuran-diols (THF-diols) (59) . Little is known regarding the biological relevance of the diepoxides, epoxyalcohols and THF-diols. Both 8,9-EET and 5,6-EET are substrates for PGHS (66-68). 5,6-EET is converted to both 5-hydroxy-PGI 1 and 5,6-epoxy-PGE 1 in rabbit kidney. Interestingly, the 5,6-epoxy-PGE 1 is equipotent to PGE 2 as a renal vasodilator whereas 5-hydroxy-PGI 1 is without activity (67). 8,9-EET is converted to 11-hydroxy-8,9-epoxyeicosatrienoic acid and 15-hydroxy-8,9-epoxyeicosatrienoic acid by PGHS. Importantly, the 11-hydroxy-8,9-epoxyeicosatrienoic acid has been shown to be a potent mitogen for rat glomerular mesangial cells (68) . All four EETs can also serve as substrates for cytosolic glutathione S-transferase to form a series of glutathione conjugates, the biological relevance of which is unknown (69). 
Biological Relevance of the EETs
The biological relevance of EETs and/or DHETs in various tissues has been the subject of a number of excellent reviews (3) (4) (5) (6) 39, 72, 73) . Herein, I will focus only on the role of these eicosanoids in kidney and cardiovascular function (summarized in Table I ).
EETs are endogenous constituents of human and rodent kidney, and EET biosynthesis occurs throughout the nephron (74) (75) (76) (77) . Moreover, EETs have been shown to contribute to integrated renal function, either by directly affecting tubular transport processes, vascular tone, and cellular proliferation, or by mediating the actions of renal hormones including renin, angiotensin II and arginine vasopressin (3, 5, 6, 73) .
For example, in the proximal tubule, EETs inhibit Na + transport and mediate the angiotensin II-induced rise in cytosolic Ca ++ (17, 78) . In the collecting duct, P450 epoxygenase metabolites inhibit the hydroosmotic effect of arginine vasopressin, decrease net Na + reabsorption and K + secretion, and increase cytosolic Ca ++ concentrations (63, 79, 80) . The EETs also have potent effects on renal vascular tone and are mitogenic in glomerular mesangial cells (12, 16, 75) . (91) . In contrast, we have shown that 11,12-EET has direct inhibitory effects on cardiac L-type Ca ++ channels reconstituted into planar lipid bilayers suggesting that EETs can either increase or decrease Ca ++ channel activity depending on the metabolic and regulatory state of the cells (55) . In an isolated-perfused rat heart model, 11,12-EET significantly improved recovery of heart contractile function following prolonged, global ischemia (41).
Concluding Remarks
During the past two decades, the contributions of many laboratories have led to an improved understanding of the biochemical, pharmacological and physiological Figure 3 
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